In contrast, the knockdown of CLDN1 or its inhibition effectively reverses GIST’s sensitivity to IM by interrupting the FGFR-mediated survival cascade (Figure 13). The gene discussed is CLDN1; the disease is gastrointestinal stromal tumor.